HIV stigma, for the first time in five years, is on the decline in the United States, despite knowledge gaps in certain ...

Efavirenz is an important drug for treating HIV infection, but it has negative effects that can significantly impact patients ...

In newly released data, lenacapavir, given via a twice-yearly injection, has shown remarkable effectiveness at eliminating ...

New Delhi: Indian public health campaigners on Wednesday said they will oppose the patent applications of a promising new but ...

Lencapavir, which is dosed only every six months, is highly effective at preventing HIV, but advocates worry its cost will blunt its impact.

Standard treatment of babies with HIV typically starts two to three months after birth and continues for decades. This new ...

"It is crucial that Dr. Mezher retracts the incorrect claims from his TikTok." The post Viral Pic Of Bloody Toilet Paper ...

Drugmaker Gilead has announced that its new, twice-a-year shot of lenacapavir ... to market lenacapavir as an HIV treatment. “With such remarkable outcomes across two Phase 3 studies ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

Progress in preventing infections was being made in the country with Europe's second-highest number of HIV cases. Then came ...

A new study reports that the type 2 diabetes drug metformin could help people living with HIV who are using antiretroviral drugs. In a previous study, after three months of using metformin ...

Drug companies typically only ensure drug access ... industry to grant permission for access while tens of thousands of new HIV infections accrue? In principle, solutions to enable access are ...